| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 9,100 | $42.49 | $386,659.00 | View Details Filing |
| Mar 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,900 | $41.73 | $246,207.00 | View Details Filing |
| Feb 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 14,043 | $32.87 | $461,593.41 | View Details Filing |
| Feb 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 957 | $31.82 | $30,451.74 | View Details Filing |
| Jan 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 12,709 | $30.47 | $387,243.23 | View Details Filing |
| Jan 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 2,191 | $31.79 | $69,651.89 | View Details Filing |
| Jan 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 100 | $32.39 | $3,239.00 | View Details Filing |